Autopsy report · NCT00941356

Evaluation of the Efficacy of Bio-K+ Cl-1285® In the Nasal Decolonization of Methicillin Resistant Staphylococcus Aureus (MRSA) Carrier Patients

“Unable to recruit patients to continue on with the study.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

Bio-K Plus International Inc.

Sponsor type

Industry

Conditions

MRSA Colonization

Interventions

Bio-K+ CL1285; Placebo

Participants

0

Sites

1

Countries

Canada

Trials that died the same way

• A Pilot/Phase II Study of Gamma Knife Radiosurgery for Brain Metastases Using 3Tesla MRI and Rational Dose Selection
  “Unable to recruit patients.” (88% match in meaning)
• Slings and Their Effect on Skin Pressure
  “unable to recruit patients for study” (84% match in meaning)
• Pharmacokinetic Study of Recombinant AT III in Neonates Undergoing ECMO
  “Unable to enroll patients into study.” (83% match in meaning)
• Propanolol and Red Cell Adhesion Non-asthmatic Children Sickle Cell Disease
  “Inability to recruit patients into the study.” (80% match in meaning)
• Discharge Counseling and Medication Therapy Management (MTM) Services After Discharge for Heart Failure Patients
  “Unable to enroll and study intended patient population.” (80% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.